Drug Trial Radar · NCT05205070
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata
Last checked: Nov 19, 2026Latest source record: May 10, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
45
Planned (sponsor's estimate)
Start
Dec 22, 2021
Primary completion
Jan 19, 2023
Study completion Mar 19, 2023
Sponsor
- Lead sponsor
- AnaptysBio, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 24, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Efficacy and safety of rosnilimab (ANB030) in subjects with moderate-to-severe Alopecia Areata
Conditions
- Alopecia Areata
Interventions
RosnilimabBiological
humanized monoclonal antibody
PlaceboBiological
Placebo solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Severity of Alopecia Tool (SALT) score at Week 24Time frame: Week 24
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
10-105
Birmingham, Alabama · Recruiting
Site10-103
Encinitas, California · Recruiting
Site 10-113
Northridge, California · Recruiting
Site 10-115
Chicago, Illinois · Recruiting
10-104
Indianapolis, Indiana · Recruiting
Site 10-109
Plainfield, Indiana · Recruiting
Site 10-116
Louisville, Kentucky · Recruiting
Site 10-117
Clarkston, Michigan · Recruiting
Site 10-111
New York, New York · Recruiting
Site 10-101
Charlotte, North Carolina · Recruiting
Site 10-102
Bexley, Ohio · Recruiting
Site 10-106
Tulsa, Oklahoma · Recruiting
10-107
Upper Saint Clair, Pennsylvania · Recruiting
10-110
Houston, Texas · Recruiting
Site 10-108
San Antonio, Texas · Recruiting
Site 10-114
Kenosha, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.